CY1104912T1 - Υποκατεστημενα πυραζολια - Google Patents
Υποκατεστημενα πυραζολιαInfo
- Publication number
- CY1104912T1 CY1104912T1 CY20061100866T CY061100866T CY1104912T1 CY 1104912 T1 CY1104912 T1 CY 1104912T1 CY 20061100866 T CY20061100866 T CY 20061100866T CY 061100866 T CY061100866 T CY 061100866T CY 1104912 T1 CY1104912 T1 CY 1104912T1
- Authority
- CY
- Cyprus
- Prior art keywords
- substituted pyrazoles
- pyrazoles
- substituted
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22517800P | 2000-08-14 | 2000-08-14 | |
PCT/US2001/025180 WO2002014317A2 (en) | 2000-08-14 | 2001-08-10 | Substituted pyrazoles |
US09/927,188 US6635633B2 (en) | 2000-08-14 | 2001-08-10 | Substituted pyrazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1104912T1 true CY1104912T1 (el) | 2009-11-04 |
Family
ID=26919363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100866T CY1104912T1 (el) | 2000-08-14 | 2006-06-26 | Υποκατεστημενα πυραζολια |
Country Status (16)
Country | Link |
---|---|
US (6) | US6635633B2 (el) |
EP (1) | EP1309592B9 (el) |
JP (1) | JP4911864B2 (el) |
CN (1) | CN1255405C (el) |
AT (1) | ATE324372T1 (el) |
AU (2) | AU2001284823B2 (el) |
CA (1) | CA2419550A1 (el) |
CY (1) | CY1104912T1 (el) |
DE (1) | DE60119124T2 (el) |
DK (1) | DK1309592T3 (el) |
ES (1) | ES2262674T3 (el) |
HK (1) | HK1052705B (el) |
MX (1) | MXPA03001420A (el) |
NZ (1) | NZ524192A (el) |
PT (1) | PT1309592E (el) |
WO (1) | WO2002014317A2 (el) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
US20050101587A9 (en) * | 2000-08-14 | 2005-05-12 | Butler Christopher R. | Method for treating allergies using substituted pyrazoles |
AU2001284823B2 (en) * | 2000-08-14 | 2006-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
US7064123B1 (en) * | 2000-12-22 | 2006-06-20 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
US20040147503A1 (en) * | 2002-06-04 | 2004-07-29 | Sheila Zipfeil | Novel compounds and compositions as cathepsin inhibitors |
ES2314224T3 (es) | 2002-03-07 | 2009-03-16 | F. Hoffmann-La Roche Ag | Inhibidores pirimidina y piridina biciclicos de p38 quinasa. |
ES2201899B1 (es) * | 2002-04-01 | 2005-06-01 | Almirall Prodesfarma, S.A. | Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos. |
ES2201907B1 (es) | 2002-05-29 | 2005-06-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos. |
US6900223B2 (en) * | 2002-07-29 | 2005-05-31 | Wyeth | Dihydrodipyrazolopyridinone inhibitors of B7-1 |
RU2478378C2 (ru) | 2002-09-24 | 2013-04-10 | Новартис Аг | Органические соединения |
US7109243B2 (en) | 2003-03-24 | 2006-09-19 | Irm Llc | Inhibitors of cathepsin S |
US7384970B2 (en) | 2003-03-24 | 2008-06-10 | Irm Llc | Inhibitors of cathepsin S |
US7173051B2 (en) | 2003-06-13 | 2007-02-06 | Irm, Llc | Inhibitors of cathepsin S |
DE10337184A1 (de) | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
US7256207B2 (en) | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
ATE412651T1 (de) | 2004-06-09 | 2008-11-15 | Glaxo Group Ltd | Pyrrolopyridinderivate |
PE20060373A1 (es) | 2004-06-24 | 2006-04-29 | Smithkline Beecham Corp | Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2 |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
WO2006117314A2 (en) * | 2005-04-30 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Novel piperidin- substituted indoles and their use as ccr-3 modulators |
EP1877447B1 (en) | 2005-05-05 | 2016-12-21 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
JP2009515833A (ja) * | 2005-10-24 | 2009-04-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター |
US8123872B2 (en) * | 2006-02-22 | 2012-02-28 | General Electric Company | Carburization process for stabilizing nickel-based superalloys |
EP2046753A2 (en) * | 2006-07-06 | 2009-04-15 | Brystol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
US20080207683A1 (en) * | 2007-02-15 | 2008-08-28 | Darin Allen | Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
US20090099157A1 (en) * | 2007-02-15 | 2009-04-16 | Ameriks Michael K | Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s |
US20090118274A1 (en) * | 2007-02-15 | 2009-05-07 | Darin Allen | Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
US20080200454A1 (en) * | 2007-02-15 | 2008-08-21 | Ameriks Michael K | Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
US20080269241A1 (en) * | 2007-02-15 | 2008-10-30 | Darin Allen | Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
EP2303250A1 (en) | 2008-06-20 | 2011-04-06 | Novartis AG | Paediatric compositions for treating1 multiple sclerosis |
EP2406249A1 (en) | 2009-03-10 | 2012-01-18 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
RS57869B1 (sr) | 2009-06-17 | 2018-12-31 | Vertex Pharma | Inhibitori replikacije virusa gripa |
RU2013132681A (ru) | 2010-12-16 | 2015-01-27 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы репликации вирусов гриппа |
UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
EP2742046A1 (en) | 2011-08-12 | 2014-06-18 | F.Hoffmann-La Roche Ag | PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
RU2674249C2 (ru) | 2012-11-05 | 2018-12-06 | НэнтБайо, Инк. | Замещенные производные индол-5-ола и их терапевтическое применение |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
RU2017141536A (ru) | 2013-03-15 | 2019-02-13 | Нэнтбайосайенс, Инк. | Замещенные производные индол-5-ола и их терапевтические применения |
ES2741444T3 (es) | 2013-11-13 | 2020-02-11 | Vertex Pharma | Inhibidores de la replicación de virus de la gripe |
RS57541B1 (sr) | 2013-11-13 | 2018-10-31 | Vertex Pharma | Postupci za pripremu inhibitora replikacije virusa gripa |
MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
JP6704416B2 (ja) | 2015-05-13 | 2020-06-03 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | インフルエンザウイルスの複製の阻害剤を調製する方法 |
EP3294735B8 (en) | 2015-05-13 | 2022-01-05 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
CN111518019B (zh) * | 2019-02-01 | 2023-10-24 | 江苏豪森药业集团有限公司 | 一种棕榈酸帕里哌酮中间体的制备方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994890A (en) | 1974-01-31 | 1976-11-30 | Chugai Seiyaku Kabushiki Kaisha | 1-Aminoalkyl, 3-phenyl indazoles |
JPS5640714B2 (el) | 1974-03-04 | 1981-09-22 | ||
JPS5936627B2 (ja) | 1975-07-25 | 1984-09-05 | 中外製薬株式会社 | インダゾ−ル誘導体の製法 |
DK27383A (da) | 1982-02-17 | 1983-08-18 | Lepetit Spa | Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner |
JPS6214765A (ja) | 1985-07-10 | 1987-01-23 | Fuyuuchiyaa Maaketsuteingu:Kk | 肉食品の製造法 |
JPH0615542B2 (ja) * | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
FR2642759B1 (fr) | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
CA2017047C (en) * | 1989-08-01 | 1999-08-17 | Jerry J. Weers | Method of scavenging hydrogen sulfide from hydrocarbons |
FR2673628B1 (fr) | 1991-03-07 | 1993-07-09 | Esteve Labor Dr | Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles. |
FR2673627B1 (fr) | 1991-03-07 | 1993-05-07 | Adir | Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
JP2818061B2 (ja) | 1991-12-10 | 1998-10-30 | 三菱電機株式会社 | 放電加工装置 |
US5792751A (en) * | 1992-04-13 | 1998-08-11 | Baylor College Of Medicine | Tranformation of cells associated with fluid spaces |
US5264576A (en) | 1992-10-22 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrazolo[4,3-c]pyridines which are intermediates |
FR2705962B1 (fr) | 1993-06-03 | 1995-07-13 | Rhone Poulenc Agrochimie | Arylpyrazoles fongicides. |
FR2712808B1 (fr) | 1993-11-25 | 1996-02-16 | Esteve Labor Dr | Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique . |
IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
US5776718A (en) | 1995-03-24 | 1998-07-07 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
KR19980703261A (ko) | 1995-03-24 | 1998-10-15 | 다니엘 이이치. 페트리 | 가역성 프로테아제 억제제 |
TW438591B (en) | 1995-06-07 | 2001-06-07 | Arris Pharm Corp | Reversible cysteine protease inhibitors |
FR2742052B1 (fr) | 1995-12-12 | 1998-04-10 | Esteve Labor Dr | Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports |
PT912601E (pt) | 1996-04-22 | 2004-04-30 | Massachusetts Inst Technology | Supressao da resposta imune via inibicao da catepsina s |
DE19620161C2 (de) * | 1996-05-08 | 2003-06-12 | Sms Demag Ag | Verfahren zum Walzen von Rohren |
BR9809147A (pt) | 1997-05-22 | 2000-08-01 | Searle & Co | Composto pirazol substituìdo, composição farmacêutica, processos para tratar um distúrbio mediado por tnf, um distúrbio mediado por quinase p38, inflamação e artrite, e, para preparar pirazóis |
WO1998056785A1 (fr) | 1997-06-12 | 1998-12-17 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de pyrazole |
US6387179B1 (en) | 1997-06-24 | 2002-05-14 | Hydril Company | Method and device for impregnating fiber bundles with resin |
US5978858A (en) * | 1997-09-30 | 1999-11-02 | Compaq Computer Corporation | Packet protocol and distributed burst engine |
KR100518690B1 (ko) | 1997-11-05 | 2005-10-05 | 노파르티스 아게 | 디펩타이드 니트릴 |
US6046281A (en) | 1997-11-06 | 2000-04-04 | University Of Massachusetts Lowell | Method for coupling living cationic polymers |
GB9806287D0 (en) | 1998-03-24 | 1998-05-20 | Synphar Lab Inc | Monobactam enzyme inhibitors |
WO1999058153A1 (en) | 1998-05-08 | 1999-11-18 | Brigham & Women's Hospital | Methods of diagnosing and modulating autoimmunity |
AU2560000A (en) | 1999-02-20 | 2000-09-04 | Astrazeneca Ab | Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin |
WO2000051998A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
TW200404789A (en) | 1999-03-15 | 2004-04-01 | Axys Pharm Inc | Novel compounds and compositions as protease inhibitors |
ES2264937T3 (es) | 1999-07-30 | 2007-02-01 | Boehringer Ingelheim Pharmaceuticals Inc. | Nuevos compuestos derivados de succinato, utiles como inhibidores de cisteina-proteasa. |
MXPA02002873A (es) | 1999-09-16 | 2002-08-30 | Axys Pharm Inc | Compuestos y composiciones farmaceuticas como inhibidores de la catepsina s. |
KR20020062312A (ko) | 1999-12-03 | 2002-07-25 | 오노 야꾸힝 고교 가부시키가이샤 | 1,3,4-옥사디아졸린 유도체 및 이들을 유효 성분으로하는 약제 |
AU2001284823B2 (en) * | 2000-08-14 | 2006-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
-
2001
- 2001-08-10 AU AU2001284823A patent/AU2001284823B2/en not_active Expired
- 2001-08-10 DE DE60119124T patent/DE60119124T2/de not_active Expired - Lifetime
- 2001-08-10 AT AT01963912T patent/ATE324372T1/de not_active IP Right Cessation
- 2001-08-10 JP JP2002519457A patent/JP4911864B2/ja not_active Expired - Lifetime
- 2001-08-10 US US09/927,188 patent/US6635633B2/en not_active Expired - Lifetime
- 2001-08-10 NZ NZ524192A patent/NZ524192A/en unknown
- 2001-08-10 CA CA002419550A patent/CA2419550A1/en not_active Withdrawn
- 2001-08-10 PT PT01963912T patent/PT1309592E/pt unknown
- 2001-08-10 CN CNB018170684A patent/CN1255405C/zh not_active Expired - Lifetime
- 2001-08-10 AU AU8482301A patent/AU8482301A/xx active Pending
- 2001-08-10 DK DK01963912T patent/DK1309592T3/da active
- 2001-08-10 WO PCT/US2001/025180 patent/WO2002014317A2/en active IP Right Grant
- 2001-08-10 EP EP01963912A patent/EP1309592B9/en not_active Expired - Lifetime
- 2001-08-10 MX MXPA03001420A patent/MXPA03001420A/es active IP Right Grant
- 2001-08-10 ES ES01963912T patent/ES2262674T3/es not_active Expired - Lifetime
-
2003
- 2003-03-28 US US10/402,694 patent/US6936603B2/en not_active Expired - Lifetime
- 2003-03-28 US US10/402,696 patent/US6951851B2/en not_active Expired - Lifetime
- 2003-03-28 US US10/401,486 patent/US6949540B2/en not_active Expired - Lifetime
- 2003-07-11 HK HK03105032.6A patent/HK1052705B/zh not_active IP Right Cessation
- 2003-08-08 US US10/638,032 patent/US20040044027A1/en not_active Abandoned
-
2005
- 2005-06-08 US US11/147,923 patent/US7265102B2/en not_active Expired - Lifetime
-
2006
- 2006-06-26 CY CY20061100866T patent/CY1104912T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20030225063A1 (en) | 2003-12-04 |
DE60119124D1 (de) | 2006-06-01 |
US20040044027A1 (en) | 2004-03-04 |
ATE324372T1 (de) | 2006-05-15 |
PT1309592E (pt) | 2006-07-31 |
US20030229075A1 (en) | 2003-12-11 |
US6936603B2 (en) | 2005-08-30 |
EP1309592B1 (en) | 2006-04-26 |
US20030225062A1 (en) | 2003-12-04 |
US20050234102A1 (en) | 2005-10-20 |
CN1468238A (zh) | 2004-01-14 |
US20020040019A1 (en) | 2002-04-04 |
CN1255405C (zh) | 2006-05-10 |
WO2002014317A3 (en) | 2002-07-04 |
DE60119124T2 (de) | 2006-11-30 |
US6949540B2 (en) | 2005-09-27 |
ES2262674T3 (es) | 2006-12-01 |
HK1052705A1 (en) | 2003-09-26 |
JP4911864B2 (ja) | 2012-04-04 |
EP1309592B9 (en) | 2007-02-28 |
US6635633B2 (en) | 2003-10-21 |
MXPA03001420A (es) | 2004-01-26 |
US7265102B2 (en) | 2007-09-04 |
HK1052705B (zh) | 2006-09-29 |
DK1309592T3 (da) | 2006-08-21 |
NZ524192A (en) | 2005-02-25 |
EP1309592A2 (en) | 2003-05-14 |
JP2004512273A (ja) | 2004-04-22 |
AU2001284823B2 (en) | 2006-11-30 |
US6951851B2 (en) | 2005-10-04 |
WO2002014317A2 (en) | 2002-02-21 |
AU8482301A (en) | 2002-02-25 |
CA2419550A1 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1309591T3 (da) | Substituerede pyrazoler | |
CY1104912T1 (el) | Υποκατεστημενα πυραζολια | |
DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
ATE333445T1 (de) | Pyrazolderivate | |
ATE307121T1 (de) | Substituierte arylpyrazine | |
DZ3409A1 (fr) | Association therapeuthique | |
ATE290000T1 (de) | Muscarinagonisten | |
ATE252099T1 (de) | Biarylcarboxamide | |
DE10136334B8 (de) | Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser | |
NO20030472L (no) | Imidazolderivater | |
ATE312098T1 (de) | Thiazinoxazolidinon | |
AR028393A1 (es) | Iminoazidas substituidas | |
ATA2932001A (de) | Schneefräse | |
ATE262530T1 (de) | Indolochinazolinone | |
ATE298751T1 (de) | 7-oxopyridoryrimidine | |
AR028336A1 (es) | 4-hidroxi-tetrahidropiridonas fenilsubstituidas | |
ATE509008T1 (de) | Sulfonylguanidine | |
ATE365721T1 (de) | Substituierte benzoylcyclohexenone | |
AR028302A1 (es) | Feniluracilos substituidos | |
AR028061A1 (es) | 2-enamino-cetonitrilos fenil-substituidos | |
ATE476423T1 (de) | Benzoylpyridazine | |
DE10052925B4 (de) | Schaukelbett | |
DE10085445T1 (de) | Drahterodierbearbeitungseinrichtung | |
AR027982A1 (es) | Aril- y heteroarilsulfonatos | |
ATE284887T1 (de) | Thienopyrrolidinone |